Top Markets
Coin of the day
GemVax&KAEL Co.,Ltd GemVax&KAEL Co.,Ltd

GemVax&KAEL Co.,Ltd

082270
Rangering i aksjer #15776
GemVax & KAEL Co., Ltd. specializes in manufacturing chemical filtration... GemVax & KAEL Co., Ltd. specializes in manufacturing chemical filtration systems and gas purification units, primarily for the semiconductor industry. The company operates through two main segments: Environmental Pollution Control and Bio Business. Its Environmental Pollution Control division focuses on creating essential filters for semiconductor and display fabrication processes, in addition to developing equipment for air quality management and odor prevention. Concurrently, the Bio Business division is dedicated to advancing its innovative telomerase-derived peptide drug, GV1001, through preparations for domestic and international Phase 2 and 3 clinical trials. These trials are designed to address various conditions, including Alzheimer's disease, benign prostatic hyperplasia, and progressive supranuclear palsy. Founded on March 10, 1998, GemVax & KAEL Co., Ltd. is headquartered in Daejeon, South Korea.
Aksjekurs
$7.54
Markedsverdi
$331.60M
Endring (1 dag)
-3.79%
Endring (1 år)
-75.66%
Land
KR
Handel GemVax&KAEL Co.,Ltd (082270)

Kategori

Inntekter for GemVax&KAEL Co.,Ltd (082270)
Inntekter i 2026 TTM: 0
Ifølge GemVax&KAEL Co.,Ltd sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for GemVax&KAEL Co.,Ltd fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
- -
US
$13.79B -
DE
- -
FR
- -
DE
$4.56B -
US